EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation of the diagnostic value of the renal resistive index as a marker of the subclinical development of cardiorenal syndrome in MMVD dogs

Barbara Szczepankiewicz iD, Urszula Pasławska, Natalia Siwińska, Krzysztof Plens, Robert Pasławski

Journal of the Renin-Angiotensin-Aldosterone System · 2021-01 · 22 (1)

DOI: 10.1177/1470320321995082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Renin-Angiotensin-Aldosterone System, online erschienen am 17.03.2021. Verfasst von Barbara Szczepankiewicz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinic of Diseases of Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental …. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Myxomatous mitral valve disease (MMVD) in dogs inevitably causes renal dysfunction. These interactions are known as the cardiorenal syndrome (CRS). The main aims of the study were to evaluate whether renal resistive index (RRI) may be useful as a non-invasive marker in subclinical stage of kidney injury in dogs with MMVD and to compare RRI with SDMA and Cyst C.

Methods

Forty-four dogs were divided into two groups: control—15 healthy dogs and the heart group—29 dogs with MMVD (ACVIM class Cc). Study protocol included: anamnesis, clinical examination, electrocardiography, echocardiography, chest radiography, abdominal ultrasonography with measurements of the renal resistive index (RRI), urine, and blood analysis.

Results

The RRI in the heart group was significantly higher 0.725 ± 0.035 versus control group 0.665 ± 0.028 ( p < 0.00085). The RRI cut-off point in dogs with stable chronic heart failure (CHF) under 8 years is 0.775, in older 0.64. RRI was similar in MMVD dogs treated with ACE-I + furosemide and dogs treated ACE-I + torasemide + pimobendan + spironolactone. There was no correlation between RRI and SDMA or Cyst C.

Conclusion

RRI is more sensitive than creatinine, SDMA and Cyst C to reveal kidney injury in MMVD dogs class Cc younger than 8 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsBiomarkersCardio-Renal SyndromeDogsFemaleHeartHeart Valve DiseasesKidneyLogistic ModelsMaleMitral ValveUltrasonography

Stichwörter der Autor:innen

Canine heart failureRRIaldosteroneechocardiographykidneymitral insufficiencymyxomatous mitral valve diseaseultrasonography

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Internal Medicine and Clinic of Diseases of Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Wrocław, Poland.
  • Institute of Veterinary Medicine, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University in Torun, Torun, Poland.
  • KCRI, Krakow, Poland.

ORCID-Profile: Barbara Szczepankiewicz

Zitieren

APA

Szczepankiewicz, B., Pasławska, U., Siwińska, N., Plens, K., & Pasławski, R. (2021). Evaluation of the diagnostic value of the renal resistive index as a marker of the subclinical development of cardiorenal syndrome in MMVD dogs. Journal of the Renin-Angiotensin-Aldosterone System, 22(1). https://doi.org/10.1177/1470320321995082

Vancouver

Szczepankiewicz B, Pasławska U, Siwińska N, Plens K, Pasławski R. Evaluation of the diagnostic value of the renal resistive index as a marker of the subclinical development of cardiorenal syndrome in MMVD dogs. Journal of the Renin-Angiotensin-Aldosterone System. 2021;22(1). doi:10.1177/1470320321995082

BibTeX
@article{Szczepankiewicz2021,
  author = {Szczepankiewicz, Barbara and Pasławska, Urszula and Siwińska, Natalia and Plens, Krzysztof and Pasławski, Robert},
  title = {Evaluation of the diagnostic value of the renal resistive index as a marker of the subclinical development of cardiorenal syndrome in MMVD dogs},
  journal = {Journal of the Renin-Angiotensin-Aldosterone System},
  year = {2021},
  volume = {22},
  number = {1},
  doi = {10.1177/1470320321995082}
}
Kostenlos starten →